How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Introduction
Cognitive impairment (CI), also referred to as cognitive dysfunction, cognitive deficit, and cognitive disorder, is a common symptom of multiple sclerosis (MS) [1]. It has relevance for many aspects of quality of life, such as maintaining employment, daily-living activities, social life, ability to drive, and benefits from in-patient rehabilitation [2]. Complex attention, information processing speed, verbal and visual–spatial memory, and executive functions are frequently impaired in MS, whereas intelligence, language, semantic memory and attention span are widely preserved.
The first signs of CI can already be found at the time of MS onset [3], [4], [5], [6], [7]. In later disease stages, CI seems to progress in terms of prevalence and severity [8]. The reported prevalence of CI in MS ranges highly, between 40% and 80%. What is the reason for such a large variance?
Two factors that potentially influence prevalence rates are sample composition and neuropsychological assessment [9]. Advanced age, progressive disease course, later disease stage, higher physical disability, fatigue, and depression are sample characteristics that tend to be associated with CI [2]. Psychometrically, the classification of CI is based on the comparison of an individual test result to the mean of a normative sample. Commonly, performance below one, one-and-a-half, or two standard deviations (SD) of the normative mean is used as cut-off for impairment classification. By definition, lower cut-offs (e.g., 1 SD) result in higher prevalence rates of CI than conservative cut-offs (e.g., 2 SD).
In neuropsychological practice however, it is common to use a battery of tests instead of a single test. This also affects the prevalence rates of CI, because the likelihood of irrelevant impaired results rises with an increasing number of obtained scores [10]. Thus, the outcome of CI is highly influenced by the utilized cut-off and the number of tests [11].
In MS, research on cognitive functions focused on finding sensitive and brief test batteries for CI in MS [12], but hardly addressed the issue of classification criteria [13]. Many studies used standard test batteries like the brief repeatable battery of neuropsychological tests (BRB-N) and defined CI as performance below the fifth percentile on about 20% of test parameters or tests [9]. However, more liberal [3], [14], [15] or conservative criteria [16], as well as non-standardized test batteries have also been used. Furthermore, some authors defined CI by employing composite indices or domain specific criteria [17], [18], [19].
To our knowledge, there is no study that compared these different classification strategies. Thus, it remains unclear when to utilize which strategy and if different strategies lead to comparable outcomes. For the first time, a review of common classification strategies for CI in MS is provided and their outcomes are compared. Moreover, we evaluate their diagnostic validity in the cognitive assessment of groups in early and late disease stages as compared to matched controls. The major goal is to promote a more homogenized use of classification strategies that allows better comparability of future studies on cognitive impairment in MS.
Section snippets
Literature search
Reference lists of recent reviews [1], [13], [20], [21], [22], [23], [24] and the online database MEDLINE were searched for original articles on cognitive impairment in MS. Search terms were combinations of “multiple sclerosis”, “cognitive impairment”, “classification” “composite” and “index” (Fig. 1).
Selection criteria
Articles were included if they met the following criteria: (1) published between 1999 and 2013 in the English language, (2) classification of cognitive impairment, and (3) classification based on
Review
Out of 921 screened records, 68 articles were included into the review (Fig. 1). 70 classification criteria could be identified and grouped into 20 distinct approaches (Table 2, Supplementary Table S1). Cognitive performance was mostly evaluated by variations of standard test batteries (BRB-N: 31, MACFIMS: 7, other: 5, nonstandard test battery: 27). Three basic classification strategies are in use:
Discussion
The present study was driven by the question of how reliable the classification of cognitive impairment in MS is across common criteria. First, a review of classification criteria used by different researchers was provided. Then the different approaches were applied to the neuropsychological data of early and late MS patients and the outcome compared in terms of prevalence rate and inter-rater reliability.
The review revealed 20 distinct approaches that have been used to classify cognitive
Potential conflict of interest disclosure
The authors have no conflicts of interest to disclose in regard to this paper.
Acknowledgment
This study is supported by: Merck Serono GmbH, Germany, a division of Merck KGaA, Darmstadt, Germany.
References (53)
- et al.
Cognitive impairment in different MS subtypes and clinically isolated syndromes
J Neurol Sci
(2008) - et al.
Cognitive impairment in multiple sclerosis
Lancet Neurol
(2008) - et al.
Cognitive changes in early MS: a call for a common framework
J Neurol Sci
(2006) - et al.
A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters
J Neurol Sci
(2008) - et al.
Quantification of five neuropsychological approaches to defining mild cognitive impairment
Am J Geriatr Psychiatr
(2009) - et al.
Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates
Am J Geriatr Psychiatr
(2010) - et al.
Verbal fluency deficits in multiple sclerosis
Neuropsychologia
(2006) Cognition in multiple sclerosis
Curr Opin Neurol
(2011)Cognitive impairment in multiple sclerosis
Mult Scler
(2009)- et al.
Cognitive impairment in probable multiple sclerosis
J Neurol Neurosurg Psychiatry
(2003)
Cognition in the early stage of multiple sclerosis
J Neurol
MRI techniques and cognitive impairment in the early phase of relapsing–remitting multiple sclerosis
Neuroradiology
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis
Mult Scler
Cognitive deterioration in patients with early multiple sclerosis: a 5-year study
J Neurol Neurosurg Psychiatry
Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis
Mult Scler
Frequency and bases of abnormal performance by healthy adults on neuropsychological testing
J Int Neuropsychol Soc
To err is human: “abnormal” neuropsychological scores and variability are common in healthy adults
Arch Clin Neuropsychol
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
Mult Scler
Cognitive impairment in multiple sclerosis
Curr Opin Neurol
How to detect cognitive dysfunction at early stages of multiple sclerosis?
Mult Scler
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis
Mult Scler
Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions
Neurology
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates
Brain
Cognitive impairment after three decades of multiple sclerosis
Eur J Neurol
Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome
Mult Scler
Cognitive deficits in multiple sclerosis: a systematic review
Arq Neuropsiquiatr
Cited by (68)
Cognitive impairment in multiple sclerosis
2024, Clinical Aspects of Multiple Sclerosis Essentials and Current UpdatesCognitive reserve as a moderating factor between EDSS and cognition in multiple sclerosis
2023, Multiple Sclerosis and Related DisordersMeasuring cognitive function by the SDMT across functional domains: Useful but not sufficient
2022, Multiple Sclerosis and Related DisordersComparing diagnostic criteria for the diagnosis of neurocognitive disorders in multiple sclerosis
2022, Multiple Sclerosis and Related DisordersCorrelation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis
2022, Multiple Sclerosis and Related Disorders